1. Home
  2. GRF vs BNR Comparison

GRF vs BNR Comparison

Compare GRF & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRF
  • BNR
  • Stock Information
  • Founded
  • GRF 1989
  • BNR 2014
  • Country
  • GRF United States
  • BNR China
  • Employees
  • GRF N/A
  • BNR N/A
  • Industry
  • GRF Finance/Investors Services
  • BNR Medical Specialities
  • Sector
  • GRF Finance
  • BNR Health Care
  • Exchange
  • GRF Nasdaq
  • BNR Nasdaq
  • Market Cap
  • GRF 42.6M
  • BNR 38.3M
  • IPO Year
  • GRF N/A
  • BNR 2020
  • Fundamental
  • Price
  • GRF $10.52
  • BNR $8.49
  • Analyst Decision
  • GRF
  • BNR
  • Analyst Count
  • GRF 0
  • BNR 0
  • Target Price
  • GRF N/A
  • BNR N/A
  • AVG Volume (30 Days)
  • GRF 3.0K
  • BNR 52.2K
  • Earning Date
  • GRF 01-01-0001
  • BNR 09-08-2025
  • Dividend Yield
  • GRF 3.70%
  • BNR N/A
  • EPS Growth
  • GRF N/A
  • BNR N/A
  • EPS
  • GRF 1.16
  • BNR N/A
  • Revenue
  • GRF N/A
  • BNR $74,862,782.00
  • Revenue This Year
  • GRF N/A
  • BNR $136.32
  • Revenue Next Year
  • GRF N/A
  • BNR N/A
  • P/E Ratio
  • GRF $8.15
  • BNR N/A
  • Revenue Growth
  • GRF N/A
  • BNR 5.20
  • 52 Week Low
  • GRF $7.93
  • BNR $2.18
  • 52 Week High
  • GRF $10.19
  • BNR $11.12
  • Technical
  • Relative Strength Index (RSI)
  • GRF 52.48
  • BNR 53.02
  • Support Level
  • GRF $10.50
  • BNR $8.30
  • Resistance Level
  • GRF $10.61
  • BNR $9.61
  • Average True Range (ATR)
  • GRF 0.10
  • BNR 0.69
  • MACD
  • GRF -0.02
  • BNR -0.13
  • Stochastic Oscillator
  • GRF 22.45
  • BNR 37.02

About GRF Eagle Capital Growth Fund Inc.

Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: